Theraclion SA (ALTHE.PA)
EUR 0.36
(-2.72%)
EUR 0.36
(-2.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.08 Million EUR | -38.83% |
| 2022 | -3.05 Million EUR | 32.81% |
| 2021 | -4.54 Million EUR | -19.25% |
| 2020 | -3.8 Million EUR | 5.23% |
| 2019 | -4.01 Million EUR | -58.95% |
| 2018 | -2.52 Million EUR | -5.2% |
| 2017 | -2.4 Million EUR | 11.15% |
| 2016 | -2.7 Million EUR | 15.97% |
| 2015 | -3.21 Million EUR | -63.6% |
| 2014 | -1.96 Million EUR | 7.15% |
| 2013 | -2.11 Million EUR | -18.76% |
| 2012 | -1.78 Million EUR | -946.72% |
| 2011 | -170.42 Thousand EUR | 78.23% |
| 2010 | -782.74 Thousand EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -3.13 Million EUR | 0.0% |
| 2023 Q2 | -2.62 Million EUR | 0.0% |
| 2023 Q4 | 1.62 Million EUR | 0.0% |
| 2023 FY | -4.23 Million EUR | -38.83% |
| 2022 Q2 | -3.35 Million EUR | 0.0% |
| 2022 FY | -3.05 Million EUR | 32.81% |
| 2022 Q4 | -3.25 Million EUR | 0.0% |
| 2021 FY | -4.54 Million EUR | -19.25% |
| 2021 Q2 | -1.91 Million EUR | 0.0% |
| 2021 Q4 | -2.69 Million EUR | 0.0% |
| 2020 Q2 | -2 Million EUR | 0.0% |
| 2020 Q4 | -1.8 Million EUR | 0.0% |
| 2020 FY | -3.8 Million EUR | 5.23% |
| 2019 Q2 | -2.37 Million EUR | 0.0% |
| 2019 Q4 | -1.64 Million EUR | 0.0% |
| 2019 FY | -4.01 Million EUR | -58.95% |
| 2018 Q4 | -863.17 Thousand EUR | 0.0% |
| 2018 Q2 | -1.66 Million EUR | 0.0% |
| 2018 FY | -2.52 Million EUR | -5.2% |
| 2017 Q2 | -1.68 Million EUR | 0.0% |
| 2017 Q4 | -717.42 Thousand EUR | 0.0% |
| 2017 FY | -2.4 Million EUR | 11.15% |
| 2016 Q4 | -1.24 Million EUR | 0.0% |
| 2016 FY | -2.7 Million EUR | 15.97% |
| 2016 Q2 | -1.45 Million EUR | 0.0% |
| 2015 Q2 | -1.69 Million EUR | 0.0% |
| 2015 Q4 | -1.52 Million EUR | 0.0% |
| 2015 FY | -3.21 Million EUR | -63.6% |
| 2014 FY | -1.96 Million EUR | 7.15% |
| 2014 Q4 | -1.06 Million EUR | 0.0% |
| 2014 Q2 | -897.39 Thousand EUR | 0.0% |
| 2013 Q3 | -529.62 Thousand EUR | 43.12% |
| 2013 Q4 | -1.18 Million EUR | -124.19% |
| 2013 FY | -2.11 Million EUR | -18.76% |
| 2013 Q2 | -931.15 Thousand EUR | 0.0% |
| 2012 FY | -1.78 Million EUR | -946.72% |
| 2012 Q4 | -529.62 Thousand EUR | -18.76% |
| 2012 Q1 | -445.95 Thousand EUR | -0.0% |
| 2012 Q2 | -445.95 Thousand EUR | 0.0% |
| 2012 Q3 | -445.95 Thousand EUR | -0.0% |
| 2011 Q3 | -42.6 Thousand EUR | 0.0% |
| 2011 FY | -170.42 Thousand EUR | 78.23% |
| 2011 Q1 | -42.6 Thousand EUR | 0.0% |
| 2011 Q2 | -42.6 Thousand EUR | 0.0% |
| 2011 Q4 | -445.95 Thousand EUR | -946.72% |
| 2010 Q3 | -195.68 Thousand EUR | 0.0% |
| 2010 Q2 | -195.68 Thousand EUR | 0.0% |
| 2010 Q1 | -195.68 Thousand EUR | 0.0% |
| 2010 FY | -782.74 Thousand EUR | 0.0% |
| 2010 Q4 | -42.6 Thousand EUR | 78.23% |
| 2009 Q4 | -195.68 Thousand EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Affluent Medical SA | -1.2 Million EUR | 9.968% |
| Bluelinea Société Anonyme | -3.84 Million EUR | 71.92% |
| Carmat SA | -30.97 Million EUR | 96.512% |
| Diagnostic Medical Systems S.A. | 15.84 Million EUR | 106.819% |
| Euromedis Groupe | 3.57 Million EUR | 130.25% |
| Eurobio Scientific Société anonyme | 53.96 Million EUR | 102.002% |
| Ikonisys S.A. | 255.82 Thousand EUR | 522.311% |
| Implanet S.A. | 3.13 Million EUR | 134.495% |
| Median Technologies SA | -2.55 Million EUR | 57.649% |
| SpineGuard SA | 3.37 Million EUR | 131.973% |
| Euroapi S.A. | 164.6 Million EUR | 100.656% |
| Guerbet SA | 197.14 Million EUR | 100.548% |
| Ion Beam Applications SA | 134.44 Million EUR | 100.804% |
| Koninklijke Philips N.V. | 7.44 Billion EUR | 100.015% |
| Sequana Medical NV | 548.04 Thousand EUR | 297.133% |